A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis

ClinicalTrials.gov ID: NCT00081471

Public ClinicalTrials.gov record NCT00081471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 29, 2026, 7:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the efficacy and safety of subcutaneous Mircera in the treatment of renal anemia in patients with chronic kidney disease who are not on dialysis and not receiving epoetin or any other erythropoietic substance. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.

Study identification

NCT ID: NCT00081471
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Hoffmann-La Roche; Industry
Enrollment: 324 participants

Conditions and interventions

Conditions

Anemia

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2004 (Type not available)
Primary completion: Jul 2006 (Actual)
Completion: Jul 2006 (Actual)
Last update posted: Nov 2, 2016

2004 – 2006

United States locations

U.S. sites: 22
U.S. states: 16
U.S. cities: 21

Facility	City	State	ZIP	Site status
Not listed	Los Angeles	California	90073	—
Not listed	Mather	California	95655	—
Not listed	Stanford	California	94305-5114	—
Not listed	Stamford	Connecticut	06902	—
Not listed	Bay Pines	Florida	33744	—
Not listed	Ocala	Florida	34471	—
Not listed	Shreveport	Louisiana	71101	—
Not listed	Boston	Massachusetts	02135	—
Not listed	Boston	Massachusetts	02215	—
Not listed	Detroit	Michigan	48236	—
Not listed	Flushing	New York	11355	—
Not listed	Cincinnati	Ohio	45220	—
Not listed	Portland	Oregon	97201-2940	—
Not listed	Allentown	Pennsylvania	18103	—
Not listed	Columbia	South Carolina	29209	—
Not listed	Nashville	Tennessee	37232	—
Not listed	Austin	Texas	78705	—
Not listed	Dallas	Texas	75216	—
Not listed	Houston	Texas	77054	—
Not listed	Burlington	Vermont	05401	—
Not listed	Salem	Virginia	24153	—
Not listed	Morgantown	West Virginia	26506	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00081471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 2, 2016 · Synced Oct 29, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00081471 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →